BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21838587)

  • 1. Risk factors for the elimination of endurance horses from competition.
    Fielding CL; Meier CA; Balch OK; Kass PH
    J Am Vet Med Assoc; 2011 Aug; 239(4):493-8. PubMed ID: 21838587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination from elite endurance rides in nine countries: a preliminary study.
    Nagy A; Murray JK; Dyson S
    Equine Vet J Suppl; 2010 Nov; (38):637-43. PubMed ID: 21059073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Horse-, rider-, venue- and environment-related risk factors for elimination from Fédération Equestre Internationale endurance rides due to lameness and metabolic reasons.
    Nagy A; Murray JK; Dyson SJ
    Equine Vet J; 2014 May; 46(3):294-9. PubMed ID: 24033509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Descriptive epidemiology and risk factors for eliminations from Fédération Equestre Internationale endurance rides due to lameness and metabolic reasons (2008-2011).
    Nagy A; Murray JK; Dyson SJ
    Equine Vet J; 2014 Jan; 46(1):38-44. PubMed ID: 23574513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the recovery check in long-distance endurance rides.
    Robert C; Benamou-Smith A; Leclerc JL
    Equine Vet J Suppl; 2002 Sep; (34):106-11. PubMed ID: 12405668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fédération Equestre Internationale endurance events: Risk factors for failure to qualify outcomes at the level of the horse, ride and rider (2010-2015).
    Bennet ED; Parkin TDH
    Vet J; 2018 Jun; 236():44-48. PubMed ID: 29871749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with completion of Fédération Équestre Internationale endurance rides (2012-2019): Modelling success to promote welfare-oriented decisions in the equestrian sport of endurance.
    Zuffa T; Bennet ED; Parkin TDH
    Prev Vet Med; 2022 Jan; 198():105534. PubMed ID: 34785438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of clinicopathologic variables and clinical examination findings to predict race elimination in endurance horses.
    Fielding CL; Meier CA; Fellers GK; Magdesian KG
    Am J Vet Res; 2017 Jan; 78(1):50-56. PubMed ID: 28029292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for lameness elimination in British endurance riding.
    Bloom F; Draper S; Bennet E; Marlin D; Williams J
    Equine Vet J; 2023 Jul; 55(4):632-641. PubMed ID: 36102466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riders' prediction of results at Fédération Equestre Internationale (FEI) endurance rides and sources of bias in questionnaires completed by riders.
    Nagy A; Dyson SJ; Murray JK
    Prev Vet Med; 2013 Nov; 112(3-4):378-86. PubMed ID: 24012242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body weight, fluid, electrolyte, and hormonal changes in horses competing in 50- and 100-mile endurance rides.
    Schott HC; McGlade KS; Molander HA; Leroux AJ; Hines MT
    Am J Vet Res; 1997 Mar; 58(3):303-9. PubMed ID: 9055979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endurance veterinarians detect physiologically compromised horses in a 160 km ride.
    Barnes A; Kingston J; Beetson S; Kuiper C
    Equine Vet J Suppl; 2010 Nov; (38):6-11. PubMed ID: 21058975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of biochemical parameters to predict metabolic elimination in endurance rides.
    Trigo P; Castejon F; Riber C; Muñoz A
    Equine Vet J Suppl; 2010 Nov; (38):142-6. PubMed ID: 21058996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Endurance Competitions and Risk Factors for Elimination in New Zealand during Six Seasons of Competition (2010/11-2015/16).
    Legg KA; Weston JF; Gee EK; Bolwell CF; Bridges JP; Rogers CW
    Animals (Basel); 2019 Aug; 9(9):. PubMed ID: 31461901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amyloid A level as a potential indicator of the status of endurance horses.
    Cywinska A; Gorecka R; Szarska E; Witkowski L; Dziekan P; Schollenberger A
    Equine Vet J Suppl; 2010 Nov; (38):23-7. PubMed ID: 21058978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and risk factors for eliminations from Fédération Equestre Internationale endurance rides between 2004-2015 in Italy.
    Di Battista C; Conte M; Pepe M; Petrizzi L; Beccati F
    Prev Vet Med; 2019 Oct; 170():104737. PubMed ID: 31421491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biochemical abnormalities in endurance horses eliminated from competition for medical complications and requiring emergency medical treatment: 30 cases (2005-2006).
    Fielding CL; Magdesian KG; Rhodes DM; Meier CA; Higgins JC
    J Vet Emerg Crit Care (San Antonio); 2009 Oct; 19(5):473-8. PubMed ID: 19821889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colic in competing endurance horses presenting to referral centres: 36 cases.
    Fielding CL; Dechant JE
    Equine Vet J; 2012 Jul; 44(4):472-5. PubMed ID: 22050046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating angiotensin converting enzyme in endurance horses: effect of exercise on blood levels and its value in predicting performance.
    De Mello Costa MF; Anderson GA; Davies HM; El-Hage CM; Slocombe RF
    Equine Vet J Suppl; 2010 Nov; (38):152-4. PubMed ID: 21058998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Speed and Cardiac Recovery Variables Predict the Probability of Elimination in Equine Endurance Events.
    Younes M; Robert C; Cottin F; Barrey E
    PLoS One; 2015; 10(8):e0137013. PubMed ID: 26322506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.